MARSHALL WACE, LLP - ONCOCYTE CORP ownership

Back to all holdings Add to watchlist

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2021$225,000
-71.7%
63,216
-54.4%
0.00%
-75.0%
Q2 2021$796,000
-57.2%
138,728
-61.3%
0.00%
-55.6%
Q1 2021$1,861,000
+4797.4%
358,670
+2168.3%
0.01%–
Q4 2020$38,000
+18.8%
15,812
+99.9%
0.00%–
Q1 2019$32,000–7,910–0.00%–
 Download
Other shareholders
ONCOCYTE CORP shareholders Q4 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders